Bradway has been president and chief operating officer of the biotechnology company Amgen since May 2010. He is responsible for the company’s global commercial operations, manufacturing operations, information technology, global government affairs, and worldwide compliance and business ethics organizations.
Bradway joined the company in 2006 as vice president operations strategy and became executive vice president and chief financial officer in April 2007.
Prior to joining the company, he was a managing director at Morgan Stanley in London where he had responsibility for the firm’s banking department and corporate finance activities in Europe.
Bradway joined Morgan Stanley in New York as a health care industry investment banker in 1985 and moved to London in 1990 where he served as head of the firm’s international health care investment banking activities until assuming broader corporate finance management responsibilities.
Bradway holds degrees from Amherst College and Harvard University.